chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: White blood cell count increased, X-ray
Clinical narrative: Information has been received from a registered nurse regarding her granddaughter who is a 18 year old patient with allergies to peanuts who on 18-JUL-2011 was vaccinated with a 0.5 ml dose of GARDASIL (Lot # not reported). Concomitant therapy included meningococcal A polysaccharide vaccine (manufacturer not reported). On 26-Jul-2011 (also reported as one week after receiving the first dose of GARDASIL in the administration series), the nurse reported that the patient developed stomach pain, low grade fever and constipation. The nurse reported one week later the patient went to a local emergency room on two separate occasions and on one visit the patient was given an enema. The patient was not admitted on either visits. The nurse reported that the patient visited her pediatrician and received no specific treatment. On 10-Aug-2011, the patient developed a 102 degrees Fahrenheit temperature and severe abdominal pain and went to the emergency room. She was admitted to the hospital with a 19,000 white blood cell count, and a CAT scan that showed a ruptured appendix with an "abscessed wall with appendiceal phlegmon." The patient had a complete blood cell count and an X-ray. The patient was treated with intravenous antibiotics and fluids. The patient's status at the time of the report was not recovered. Action taken in relation to therapy was not reported at the time of the report. Information received from a telephone call on 16-Aug-2011 with the nurse, who reported the patient's treatment with antibiotics had worked and her abscess was "cured" and that the patient should be home within the next couple of days. The reporter felt that the events of stomach pain, low grade fever, constipation, "went to a local emergency room on 2 separate occasions and on one visit was given on enema", 102 Fahrenheit temperature, severe abdominal pain, white blood cell count of 19,000, ruptured appendix with an abscessed wall with appendiceal phlegmon were disabling and life threatening. The reporting registered nurse contacted during telephone follow-up would not supply the patient's name, date of birth, lot number, and healthcare provider's name and contact information. No additional information provided. Additional information has been requested.
Sex: U
Vaccine: PNC13
Symptoms: Irritability, Neuralgic amyotrophy
Clinical narrative: This is a spontaneous report from a contactable physician. A patient (sex and age unknown) was administered a dose of PREVNAR 13 on an unknown date. Relevant medical history was unknown. Relevant concomitant medications were unknown. Vaccines given on the same day were unknown. Vaccines taken within the last four weeks were unknown. On an unknown date at unknown time after vaccination, the patient was diagnosed with Parsonage-Turner Syndrome and experienced unspecified irritation. Relevant lab data was unknown. At the time of the report the clinical outcome of the events were unknown. Company Clinical Evaluation comment: Based on the information provided in the case, this individual report would seem to modify the benefit/risk profile of PREVNAR 13.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HIBV, MMRV, PNC13
Symptoms: Culture throat, Pyrexia, Urticaria
Clinical narrative: Fever 103 / urticaria
Age: 56.0
Sex: M
Vaccine: FLUX
Symptoms: Asthenia, Fatigue, Feeling abnormal, Malaise, Oropharyngeal pain
Clinical narrative: Fatigue, brain fogginess, weakness, sore throat, general malaise
Age: 38.0
Sex: F
Vaccine: PER, TTOX
Symptoms: Dyskinesia, Injected limb mobility decreased, Injection site pain, Movement disorder, Muscle spasms
Clinical narrative: Unable to locate vaccine type - told it was tetanus booster with pertussis, a 'new' vaccine. Symptoms increasing from 8/24 to present (8/29) including intense pain radiating to fingertips of L arm, across L scapula, up L side of neck. Pain @ injection site, cannot lift arm voluntarily. Spasms of hand & fingers, involutary mvmt, delayed mvmt, tremor, muscle weakness.
Age: 38.0
Sex: F
Vaccine: PER, TTOX
Symptoms: Muscular weakness, Musculoskeletal pain, Neck pain, Pain in extremity, Tremor
Clinical narrative: Unable to locate vaccine type - told it was tetanus booster with pertussis, a 'new' vaccine. Symptoms increasing from 8/24 to present (8/29) including intense pain radiating to fingertips of L arm, across L scapula, up L side of neck. Pain @ injection site, cannot lift arm voluntarily. Spasms of hand & fingers, involutary mvmt, delayed mvmt, tremor, muscle weakness.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Blood test, Dyspnoea, Oropharyngeal pain, Pharyngitis, Rash
Clinical narrative: Patient had a sore throat that turned into what was thought to be an infection. Was treated with antibiotics for ten days, during those days she complained of trouble breathing. On 8/24/2011 she developed a rash on her face/ears, Dr said she may be having an allergic reaction to something she had eaten, or some viral. Was sent home. The next morning patient woke up with a rash ALL over her body, again, I took her to the pediatrician. I felt very confident this was a MMR reaction causing my daughter to have the measles. The Dr's said they had not seen the measles before it was so rare. They tested her to rule out Fifths disease just to be sure. She has red spots on the roof of her mouth as well. I was told to take her home and keep her there until results of bloodwork were in. Waiting on these results as of now. Patient is six days into this measle rash, it began to dissapate on the fourth day mildly, the sixth day it was much less noticeabe. I have documented pictures of this "RARE" reaction in hopes to help other children and families. There has been no treatment, other than oatmeal bathe and Benadryl. I am awaiting to see if my baby will be scared from this.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Rash erythematous, Rash generalised, Streptococcus test
Clinical narrative: Patient had a sore throat that turned into what was thought to be an infection. Was treated with antibiotics for ten days, during those days she complained of trouble breathing. On 8/24/2011 she developed a rash on her face/ears, Dr said she may be having an allergic reaction to something she had eaten, or some viral. Was sent home. The next morning patient woke up with a rash ALL over her body, again, I took her to the pediatrician. I felt very confident this was a MMR reaction causing my daughter to have the measles. The Dr's said they had not seen the measles before it was so rare. They tested her to rule out Fifths disease just to be sure. She has red spots on the roof of her mouth as well. I was told to take her home and keep her there until results of bloodwork were in. Waiting on these results as of now. Patient is six days into this measle rash, it began to dissapate on the fourth day mildly, the sixth day it was much less noticeabe. I have documented pictures of this "RARE" reaction in hopes to help other children and families. There has been no treatment, other than oatmeal bathe and Benadryl. I am awaiting to see if my baby will be scared from this.
Age: 1.04
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Blood culture, C-reactive protein, Convulsion, Cyanosis, Full blood count normal
Clinical narrative: Fever 102.7 so gave baby 100mg Motrin.  Not 2 minutes later he began seizing, eyes rolling back and lips turning blue.  Continued for a period of 2-4 minutes.  EMS was called and was transported to nearest hospital.  We controlled his temperature and he was back to baseline within 24 hours.  No signs of infection on CBC.
Age: 1.04
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Gaze palsy, Metabolic function test, Pyrexia
Clinical narrative: Fever 102.7 so gave baby 100mg Motrin.  Not 2 minutes later he began seizing, eyes rolling back and lips turning blue.  Continued for a period of 2-4 minutes.  EMS was called and was transported to nearest hospital.  We controlled his temperature and he was back to baseline within 24 hours.  No signs of infection on CBC.
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Lymphadenopathy, Nausea, Pyrexia, Swelling, T-lymphocyte count decreased
Clinical narrative: listed before
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Localized reaction to injection area.  Unknow time of when it started.  Red and raised area approximately 8 x 10 cm.  Patient states it itches and burns at times.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Contusion, Erythema, Pruritus
Clinical narrative: After receiving the Zostavax vaccine, the next day my arm began to itch.  When I looked at it there was a red area about an inch or so wide and three inches long.  To the side of that my arm bruised along the side about the same dimensions.  This lasted for approximately a week and a half then gradually faded.  Was not painful.
Age: 52.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Erythema, Induration, Pain, Pyrexia
Clinical narrative: Tdap administered 8/22/11. Localized induration & erythema began 8/23/11, induration 6 cm by 8/24/11. On 8/24/11 & 8/25/11, low grade (>100 degrees) fever, chills, & generalized achiness, resolved by 8/26. On 8/26, 5.5 cm localized induration persists.
Age: 68.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: C/o injection site mild soreness ache slight redness x 3 days post 8/19/11. On 8/24/11 redness painful tenderness site 1 3/4" x 3" without fever or s/s of infection. Inst to apply cool compress & start analgesic. 8/29/11 decrease in symptoms feeling better.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Red swollen circle size of dime on (R) arm.
Age: 1.57
Sex: F
Vaccine: DTAP, HIBV, MMRV, PNC13
Symptoms: Rash, Rash macular, Rash pruritic
Clinical narrative: Fine macular rash on head (scalp), trunk, and extremities. No fever or other symptoms. Rash is slightly itchy. Started 10 days after MMR vaccine.
Age: 87.0
Sex: F
Vaccine: FLU3
Symptoms: Aphagia, Cough, Headache, Musculoskeletal stiffness, Oropharyngeal pain
Clinical narrative: Patient received vaccine 8/16 in AM. That night (she reported) she was awakened w/ a HA. She developed a sore throat, cough, and couldn't "move her neck". For 2 full days she could not eat. Sx cleared Sunday 8/21/11 & she reported them to me 8/22/11.
Age: 62.0
Sex: F
Vaccine: PPV
Symptoms: Axillary pain, Injection site erythema, Injection site pain
Clinical narrative: Site sore on 8/26/11, pain moved to underarm area into armpit. Redness about 4 inches around site appeared 8/28/11. Sent to urgent care. MD told her to put BENADRYL on it & take Doxycycline 100mg BID.
Age: 4.0
Sex: F
Vaccine: MMR, PNC13
Symptoms: Injection site erythema
Clinical narrative: Small red spot on (R) arm.
Age: 0.21
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site swelling
Clinical narrative: Immediately after client received PREVNAR 13 vaccine IM in RVL this nurse observed redness/swelling of (Rt) thigh. Applied ice pack wrapped in several paper towels for 2 to 3 minutes and observed swelling to decrease. Client monitored for 45 minutes. No swelling or redness present to (Rt) thigh when left facility. Follow up phone call to parent x 2 in 48 hours. No swelling/redness to (Rt) thigh. Equal movement of legs per client's mother.
Age: 16.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Dehydration, Headache, Pyrexia
Clinical narrative: High fever 103 degrees. Dehydrated, HA. ER visit.
Age: 12.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL, DTAP, MNQ, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness & swelling at site of injection, day one following injection. Increase in size of redness on day two (10cm x 6.5cm).
Age: 52.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Lt arm from shoulder to mid lower arm is red and slightly swollen. Complains of soreness and itching. Is still about the same a week later.
Age: 28.0
Sex: F
Vaccine: DTAP
Symptoms: Abdominal pain, Asthenia, Headache, Nausea, Pain
Clinical narrative: Fever (105), headache, nausea, shooting pain in abdomen, pain in arm, swelling in tongue, and weakness.  It took three days to recover.
Age: 28.0
Sex: F
Vaccine: DTAP
Symptoms: Pain in extremity, Pyrexia, Swollen tongue
Clinical narrative: Fever (105), headache, nausea, shooting pain in abdomen, pain in arm, swelling in tongue, and weakness.  It took three days to recover.
Age: 11.0
Sex: F
Vaccine: DTAP, MNQ
Symptoms: Arthralgia, Muscular weakness, Pain in extremity
Clinical narrative: PAIN AND WEAKNESS BILATERAL FEET THAT THEN ASCENDING TO THE KNEES
Age: 28.0
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Caesarean section, Drug exposure during pregnancy, Neonatal disorder, Premature delivery, Twin pregnancy
Clinical narrative: This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 28-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline) for prophylaxis during pregnancy. Concurrent medical conditions included cat bite. On 19 November 2010 at 11:50 the subject received 5th dose of BOOSTRIX (.5 ml, unknown). Her last menstrual period was on an unspecified date and estimated date of delivery is 10 July 2011. The subject was exposed to BOOSTRIX during the first trimester. On 19 November 2010, at the time of vaccination with BOOSTRIX, the subject experienced vaccine exposure during pregnancy. At the time of report the outcome of the pregnancy was unknown. Follow-up information was received on 09 February 2011. It was reported that the conception was normal. No significant details regarding the pregnancy were reported. Follow-up information was received on 17 August 2011. It was reported that the patient gave birth to male twins via cesarean section, prematurely, at 34 weeks gestation on 03 June 2011. The infants were reported to be healthy, however, low birth weight was noted. Weight of one twin was 4.0 pounds and the other was 3 pounds and 4 ounces. Refer to case numbers A0942393A and B for details of the twins.
Age: 28.0
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Caesarean section, Drug exposure during pregnancy, Neonatal disorder, Premature delivery
Clinical narrative: This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 28-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline) for prophylaxis during pregnancy. Concurrent medical conditions included cat bite. On 19 November 2010 at 11:50 the subject received 5th dose of BOOSTRIX (.5 ml, unknown). Her last menstrual period was on an unspecified date and estimated date of delivery is 10 July 2011. The subject was exposed to BOOSTRIX during the first trimester. On 19 November 2010, at the time of vaccination with BOOSTRIX, the subject experienced vaccine exposure during pregnancy. At the time of report the outcome of the pregnancy was unknown. Follow-up information was received on 09 February 2011. It was reported that the conception was normal. No significant details regarding the pregnancy were reported. Follow-up information was received on 17 August 2011. It was reported that the patient gave birth to male twins via cesarean section, prematurely, at 34 weeks gestation on 03 June 2011. The infants were reported to be healthy, however, low birth weight was noted. Weight of one twin was 4.0 pounds and the other was 3 pounds and 4 ounces. Refer to case numbers A0942393A and B for details of the twins.
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Caesarean section, Drug exposure during pregnancy, Neonatal disorder, Premature delivery, Twin pregnancy
Clinical narrative: This prospective pregnancy case was reported by a healthcare professional and described the occurrence of premature birth of a male neonate (twin) subject exposed to BOOSTRIX (GlaxoSmithKline) taken by the mother for prophylaxis during pregnancy. Parental medical conditions included cat bite. On 19 November 2010 at 11:50 the mother of the subject received 5th dose of BOOSTRIX (.5 ml, unknown). Her last menstrual period was on an unspecified date and estimated date of delivery is 10 July 2011. The subject was exposed to BOOSTRIX during the first trimester. On 19 November 2010, at the time of vaccination with BOOSTRIX, the subject experienced vaccine exposure in utero. It was reported that the conception was normal. Follow-up information received on 17 August 2011 indicated that the mother gave birth to male twins via cesarean section, prematurely, at 34 weeks gestation on 03 June 2011. The infants were reported to be healthy, however, low birth weight was noted. The weight of the twin for this report was 4 pounds. The neonate failed a hearing and vision screen. The outcome and attribution of the events to BOOSTRIX was not reported. For details concerning the other twin report, refer to case number A0942393A and for the mother report refer to case number A0894673A.
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Caesarean section, Drug exposure during pregnancy, Neonatal disorder, Premature delivery
Clinical narrative: This prospective pregnancy case was reported by a healthcare professional and described the occurrence of premature birth of a male neonate (twin) subject exposed to BOOSTRIX (GlaxoSmithKline) taken by the mother for prophylaxis during pregnancy. Parental medical conditions included cat bite. On 19 November 2010 at 11:50 the mother of the subject received 5th dose of BOOSTRIX (.5 ml, unknown). Her last menstrual period was on an unspecified date and estimated date of delivery is 10 July 2011. The subject was exposed to BOOSTRIX during the first trimester. On 19 November 2010, at the time of vaccination with BOOSTRIX, the subject experienced vaccine exposure in utero. It was reported that the conception was normal. Follow-up information received on 17 August 2011 indicated that the mother gave birth to male twins via cesarean section, prematurely, at 34 weeks gestation on 03 June 2011. The infants were reported to be healthy, however, low birth weight was noted. The weight of the twin for this report was 4 pounds. The neonate failed a hearing and vision screen. The outcome and attribution of the events to BOOSTRIX was not reported. For details concerning the other twin report, refer to case number A0942393A and for the mother report refer to case number A0894673A.
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Caesarean section, Drug exposure during pregnancy, Neonatal disorder, Premature delivery, Twin pregnancy
Clinical narrative: This prospective pregnancy case was reported by a healthcare professional and described the occurrence of premature birth of a male neonate (twin) subject exposed to BOOSTRIX (GlaxoSmithKline) taken by the mother for prophylaxis during pregnancy. Parental medical conditions included cat bite. On 19 November 2010 at 11:50 the mother of the subject received 5th dose of BOOSTRIX  (.5 ml, unknown). Her last menstrual period was on an unspecified date and estimated date of delivery is 10 July 2011. The subject was exposed to BOOSTRIX during the first trimester. On 19 November 2010, at the time of vaccination with BOOSTRIX, the subject experienced vaccine exposure in utero. It was reported that the conception was normal. Follow-up information received on 17 August 2011 indicated that the mother gave birth to male twins via cesarean section, prematurely, at 34 weeks gestation on 03 June 2011. The infants were reported to be healthy, however, low birth weight was noted. The weight of the twin for this report was 3 pounds and 4 ounces. The neonate failed a hearing and vision screen. The outcome and attribution of the events to BOOSTRIX was not reported. For details concerning the other twin report, refer to case number A0942393B and for the mother report refer to case number A0894673A.
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Caesarean section, Drug exposure during pregnancy, Neonatal disorder, Premature delivery
Clinical narrative: This prospective pregnancy case was reported by a healthcare professional and described the occurrence of premature birth of a male neonate (twin) subject exposed to BOOSTRIX (GlaxoSmithKline) taken by the mother for prophylaxis during pregnancy. Parental medical conditions included cat bite. On 19 November 2010 at 11:50 the mother of the subject received 5th dose of BOOSTRIX  (.5 ml, unknown). Her last menstrual period was on an unspecified date and estimated date of delivery is 10 July 2011. The subject was exposed to BOOSTRIX during the first trimester. On 19 November 2010, at the time of vaccination with BOOSTRIX, the subject experienced vaccine exposure in utero. It was reported that the conception was normal. Follow-up information received on 17 August 2011 indicated that the mother gave birth to male twins via cesarean section, prematurely, at 34 weeks gestation on 03 June 2011. The infants were reported to be healthy, however, low birth weight was noted. The weight of the twin for this report was 3 pounds and 4 ounces. The neonate failed a hearing and vision screen. The outcome and attribution of the events to BOOSTRIX was not reported. For details concerning the other twin report, refer to case number A0942393B and for the mother report refer to case number A0894673A.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Conjunctivitis infective, Ear, nose and throat examination normal, Eye pruritus, Eye swelling, Eyelid margin crusting
Clinical narrative: Chief Complaint: Matted swollen red eyes, swollen lips and throat. Got flu shot yesterday feels it may be a reaction to this. Level 3 Ht and wt deferred. Received Fluvax first time yesterday about 3pm--immediately felt unusual. Then about 9pm last pm started with throat itching, swelling, eyes itching, lips swelling, some wheezing. No h.o. asthma. No other new foods/exposures yesterday. Also thinks developing pink eye--both eye matted this am.  OBJECTIVE  TMP:98.00 (36.6 C), PU:82, RS:16, BP:129/77, PA:4, O2:100 gen: nad heent: eye injected; tms normal light reflex au turbinates pale, boggy throat post pharynx hyperemic no exudates neck: supple no adenopathy lungs:cta cor: rrr without murmur skin: lower lip edematous ASSESSMENT   1) allergic reaction to Fluvax [P] ; AUG 26, 2011
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Hypersensitivity, Immediate post-injection reaction, Lip swelling, Ocular hyperaemia, Pharyngeal oedema
Clinical narrative: Chief Complaint: Matted swollen red eyes, swollen lips and throat. Got flu shot yesterday feels it may be a reaction to this. Level 3 Ht and wt deferred. Received Fluvax first time yesterday about 3pm--immediately felt unusual. Then about 9pm last pm started with throat itching, swelling, eyes itching, lips swelling, some wheezing. No h.o. asthma. No other new foods/exposures yesterday. Also thinks developing pink eye--both eye matted this am.  OBJECTIVE  TMP:98.00 (36.6 C), PU:82, RS:16, BP:129/77, PA:4, O2:100 gen: nad heent: eye injected; tms normal light reflex au turbinates pale, boggy throat post pharynx hyperemic no exudates neck: supple no adenopathy lungs:cta cor: rrr without murmur skin: lower lip edematous ASSESSMENT   1) allergic reaction to Fluvax [P] ; AUG 26, 2011
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Throat irritation, Wheezing
Clinical narrative: Chief Complaint: Matted swollen red eyes, swollen lips and throat. Got flu shot yesterday feels it may be a reaction to this. Level 3 Ht and wt deferred. Received Fluvax first time yesterday about 3pm--immediately felt unusual. Then about 9pm last pm started with throat itching, swelling, eyes itching, lips swelling, some wheezing. No h.o. asthma. No other new foods/exposures yesterday. Also thinks developing pink eye--both eye matted this am.  OBJECTIVE  TMP:98.00 (36.6 C), PU:82, RS:16, BP:129/77, PA:4, O2:100 gen: nad heent: eye injected; tms normal light reflex au turbinates pale, boggy throat post pharynx hyperemic no exudates neck: supple no adenopathy lungs:cta cor: rrr without murmur skin: lower lip edematous ASSESSMENT   1) allergic reaction to Fluvax [P] ; AUG 26, 2011
Age: 35.0
Sex: M
Vaccine: TDAP
Symptoms: Arthralgia, Crying, Disorientation, Fatigue, Gait disturbance
Clinical narrative: Mild joint aches 9-10:00 AM Severe Joint aches, mild fatigue 10-11:00AM Severe Joint aches, extreme fatigue, fever, disorientation. 11:00AM-11:30AM Severe Joint aches, extreme fatigue, disorientation, visual hallucination, irritability, pronounced "unexplainable" crying. 11:30AM-12:30PM Severe Joint aches, extreme fatigue, disorientation, irritability (crying, yelling), near paralysis of limbs, collapse, instability. 12:30PM-1:30PM Moved to bed, given 600mg ibuprofen, rests 1:30PM Severe fatigue, body aches. No longer irritable, not as disoriented 2:45PM  Severe fatigue, slight body aches, difficulty walking or other movements (very slow). 2:45PM-12AM 08/28/2011 fatigue, fever, minor joint soreness. 08/29/2011 slight fatigue, un-easy on feet at times.
Age: 35.0
Sex: M
Vaccine: TDAP
Symptoms: Hallucination, visual, Irritability, Movement disorder, Pain, Paraesthesia
Clinical narrative: Mild joint aches 9-10:00 AM Severe Joint aches, mild fatigue 10-11:00AM Severe Joint aches, extreme fatigue, fever, disorientation. 11:00AM-11:30AM Severe Joint aches, extreme fatigue, disorientation, visual hallucination, irritability, pronounced "unexplainable" crying. 11:30AM-12:30PM Severe Joint aches, extreme fatigue, disorientation, irritability (crying, yelling), near paralysis of limbs, collapse, instability. 12:30PM-1:30PM Moved to bed, given 600mg ibuprofen, rests 1:30PM Severe fatigue, body aches. No longer irritable, not as disoriented 2:45PM  Severe fatigue, slight body aches, difficulty walking or other movements (very slow). 2:45PM-12AM 08/28/2011 fatigue, fever, minor joint soreness. 08/29/2011 slight fatigue, un-easy on feet at times.
Age: 35.0
Sex: M
Vaccine: TDAP
Symptoms: Pyrexia, Syncope
Clinical narrative: Mild joint aches 9-10:00 AM Severe Joint aches, mild fatigue 10-11:00AM Severe Joint aches, extreme fatigue, fever, disorientation. 11:00AM-11:30AM Severe Joint aches, extreme fatigue, disorientation, visual hallucination, irritability, pronounced "unexplainable" crying. 11:30AM-12:30PM Severe Joint aches, extreme fatigue, disorientation, irritability (crying, yelling), near paralysis of limbs, collapse, instability. 12:30PM-1:30PM Moved to bed, given 600mg ibuprofen, rests 1:30PM Severe fatigue, body aches. No longer irritable, not as disoriented 2:45PM  Severe fatigue, slight body aches, difficulty walking or other movements (very slow). 2:45PM-12AM 08/28/2011 fatigue, fever, minor joint soreness. 08/29/2011 slight fatigue, un-easy on feet at times.
Age: 29.0
Sex: M
Vaccine: SMALL
Symptoms: Chills, Fatigue, Pyrexia, Rash generalised, Rash maculo-papular
Clinical narrative: GENERALIZED DIFFUSE MACULOPAPULAR RASH,  MILD FEVER/FATIGUE/CHILLS
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Rash erythematous, Urticaria
Clinical narrative: Started out as tiny red bumps on back and by 8/29/2011 AM it had spread to stomach, chest, legs, face, groin area. On back the tiny red bumps are now raised red welts/bumps. Doctor said just to treat the itchy symptoms with hydrocortisone cream.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Hyperhidrosis, Pain, Pyrexia
Clinical narrative: FEVER, CHILLS, ACHES, SWEATS X 3 DAYS
Age: 57.0
Sex: F
Vaccine: FLUX
Symptoms: Blood test abnormal, Infection, Injection site reaction, Mobility decreased, Nuclear magnetic resonance imaging abnormal
Clinical narrative: Fever began while at work.  After work temp was taken and remained @ 102.4 for four days.  Infection continued to the point that I was unable to move my arm.  After antibiotic I could move my arm only a little for a year.  The site of the vaccine continues to flare up and is currently sore, even after 2 years.
Age: 57.0
Sex: F
Vaccine: FLUX
Symptoms: Pyrexia, Vaccination site pain, White blood cell count increased
Clinical narrative: Fever began while at work.  After work temp was taken and remained @ 102.4 for four days.  Infection continued to the point that I was unable to move my arm.  After antibiotic I could move my arm only a little for a year.  The site of the vaccine continues to flare up and is currently sore, even after 2 years.
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Activities of daily living impaired, Chills, Decreased appetite, Headache, Influenza like illness
Clinical narrative: Severe chills, fever, headache, vomiting, flu like symptoms, unable to eat or get up
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Pyrexia, Vomiting
Clinical narrative: Severe chills, fever, headache, vomiting, flu like symptoms, unable to eat or get up
Age: 60.0
Sex: M
Vaccine: TDAP
Symptoms: Asthenia, Chills, Headache, Nausea, Pyrexia
Clinical narrative: Severe chills, fever, shaking, weak, nausea, headache, sleepy
Age: 60.0
Sex: M
Vaccine: TDAP
Symptoms: Somnolence, Tremor
Clinical narrative: Severe chills, fever, shaking, weak, nausea, headache, sleepy
Age: 16.0
Sex: M
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Excoriation, Fall, Haemoglobin normal, Head injury, Syncope
Clinical narrative: At Approximately 15 minutes after vaccines were administered to patient, patient had ? seizure and syncope episode.  As he was falling to the floor from a standing position he hit his head on the cabinet in the reception area of the clinic.  The Medical Assistant attempted to prevent patient's fall. Abrasion was noted on patient's forehead after fall.  No loss of consciousness noted.  Pediatrician called to the scene. 911 called. Oxygen at 8 liters/min applied via mask.  Neosporin applied to forehead. Patient transferred to ED via ambulance.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Oropharyngeal pain
Clinical narrative: Area where she received the injection became red and swollen.  She said its on the whole back of her arm, and approximately 6 inches x 3 inches.  She also mentioned a sore throat since receiving the injection.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, HEPA, MMR
Symptoms: Demyelinating polyneuropathy, Electromyogram abnormal, Guillain-Barre syndrome, Inflammation, Lumbar puncture abnormal
Clinical narrative: Patient developed arm and leg weakness 1-2 weeks onset after 5 year old vaccinations.  Weakness progressed and was diagnosed with Guillain-Barre Syndrome.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, HEPA, MMR
Symptoms: Muscular weakness
Clinical narrative: Patient developed arm and leg weakness 1-2 weeks onset after 5 year old vaccinations.  Weakness progressed and was diagnosed with Guillain-Barre Syndrome.
Age: 7.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Dyspnoea, Pain in extremity, Pyrexia, Speech disorder, Swelling face
Clinical narrative: He had a fever since 8/5 pm then on 8/6 he had a lot of arm pain.  His face was swollen, he couldn't hardly breathe or talk.  We took him to the ER where he was given Benadryl and steroids.
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Severe burning/itching day of vaccination, 2inch diameter raised swollen are where shot was given present the following day.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, PNC13
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: (L) arm x2 vaccines given - deltoid. Erythema, swelling, and itching, warmth to touch measures 12cm x 10cm.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Acne, Pruritus, Rash, Rash morbilliform
Clinical narrative: Pt reported rash onset 8/25 or 8/26 on neck, back, chest & abdomen. Describes as pimple like or measles like with pruritus, seen by primary care Dr. "rash very non descript". Felt possible drug reaction from NORVASC started approx 1 wk ago. NORVASC Dc'd.
Age: 71.0
Sex: F
Vaccine: TDAP
Symptoms: Chest discomfort, Erythema, Headache, Induration, Myalgia
Clinical narrative: No reaction first 2 days - 3rd day muscle soreness 4th day arm itchy, red, swollen - 5th day headache, tight chest no hives. 11 x 17 cm red swollen indurated (L) arm.
Age: 71.0
Sex: F
Vaccine: TDAP
Symptoms: Oedema peripheral, Pruritus
Clinical narrative: No reaction first 2 days - 3rd day muscle soreness 4th day arm itchy, red, swollen - 5th day headache, tight chest no hives. 11 x 17 cm red swollen indurated (L) arm.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Erythema, Swelling
Clinical narrative: Patient called a physician on call 2 days after vaccination, complaining of swelling "golf ball size", redness, questionable vesicles.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Decreased appetite, Headache, Immediate post-injection reaction, Injection site pruritus, Injection site rash
Clinical narrative: 8/26/11 Vaccine given at 10:30AM (Lt) arm, client noticed it itched right after he received injection, HA started 10pm, poor appetite at dinner 5pm, at 10pm TYLENOL 1 tab, BENADRYL 25mg PO, at 11pm vomiting started lasting approximately 30 mins, went to sleep, at 5-6AM 8/27/11 vomited, then slept until 9:45AM, at 11AM giving sips of warm Coke, then noticed fever welted & rash around the injection site down to his elbow on (Lt) arm only. By 5pm feeling better fever gone & rash and welts gone 8/27/11.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site reaction, Pyrexia, Urticaria, Vomiting
Clinical narrative: 8/26/11 Vaccine given at 10:30AM (Lt) arm, client noticed it itched right after he received injection, HA started 10pm, poor appetite at dinner 5pm, at 10pm TYLENOL 1 tab, BENADRYL 25mg PO, at 11pm vomiting started lasting approximately 30 mins, went to sleep, at 5-6AM 8/27/11 vomited, then slept until 9:45AM, at 11AM giving sips of warm Coke, then noticed fever welted & rash around the injection site down to his elbow on (Lt) arm only. By 5pm feeling better fever gone & rash and welts gone 8/27/11.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL, DTAP, MNQ, VARCEL
Symptoms: Erythema, Oedema peripheral, Skin warm
Clinical narrative: MENVEO vaccine administered (R) arm on 8/25/11. 8/26/11 parent called to say arm red, swollen, warm to touch. 8/27/11 pt. seen in office for continuation of above sx. Pt. to take BENADRYL prn. Cool compresses prn.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HIBV, MMR, VARCEL
Symptoms: Injection site swelling, Urticaria
Clinical narrative: Swelling to upper right arm "whelp about 3 inches in diameter" per mother's report. Seen in ER 8/24/11.
Age: 24.0
Sex: M
Vaccine: FLU3
Symptoms: Dyspnoea, Erythema, Heart rate increased, Lip swelling, Local swelling
Clinical narrative: Pt began itching, turned red from head to toe, face & neck (lips) swollen, knots on neck, white knuckles, welts all over upper body, fast heartbeat, trouble breathing, gave EPIPEN & 50mg BENADRYL & called 911.
Age: 24.0
Sex: M
Vaccine: FLU3
Symptoms: Nodule, Pruritus, Swelling face, Urticaria
Clinical narrative: Pt began itching, turned red from head to toe, face & neck (lips) swollen, knots on neck, white knuckles, welts all over upper body, fast heartbeat, trouble breathing, gave EPIPEN & 50mg BENADRYL & called 911.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Eye swelling, Rhinorrhoea
Clinical narrative: Day following injection pt experienced very runny nose and eyes swollen shut (8/20/11) lasted about 1 day.
Age: 74.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site reaction
Clinical narrative: Patient called 2 days after administration. She had onset of injection site reaction 24hours after flu vaccine administration. Advised to use cold compresses and BENADRYL (if appropriate).
Age: 2.0
Sex: F
Vaccine: PNC13
Symptoms: Convulsion, Laboratory test normal, Lethargy, Pyrexia, Vomiting
Clinical narrative: Father took pt to ER with CC of seizure & fevers. Fevers started 8-22-11 and escalated with seizure on 8-24-11, EMS called & pt taken to ER. 106F on ER admission with emesis in ER. Tx incl. TYLENOL and fluids; fever then diminished. Lethargic condition steadily improved. Discharged 8-25-11 - stable and VS were WNL.
Age: 5.0
Sex: F
Vaccine: DTAP, MMR
Symptoms: Blood culture, C-reactive protein, Differential white blood cell count, Full blood count, Injection site reaction
Clinical narrative: (R) thigh reaction to DTAP vaccine -> cellulitis?
Age: 5.0
Sex: F
Vaccine: DTAP, MMR
Symptoms: Red blood cell sedimentation rate, Ultrasound scan
Clinical narrative: (R) thigh reaction to DTAP vaccine -> cellulitis?
Age: 1.01
Sex: M
Vaccine: PNC13
Symptoms: Rash
Clinical narrative: Bumps on face, legs.
Age: 49.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Amnesia, Chronic inflammatory demyelinating polyradiculoneuropathy, Depression, Disturbance in attention, Dysphemia
Clinical narrative: Severe tremors, pain & numbness in feet & legs, and it has moved to upper extremities, trouble concentrating & having memory loss. CIDP, severe depression, speak consists of constant stuttering.
Age: 49.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Hypoaesthesia, Nerve stimulation test, Nuclear magnetic resonance imaging, Pain in extremity, Tremor
Clinical narrative: Severe tremors, pain & numbness in feet & legs, and it has moved to upper extremities, trouble concentrating & having memory loss. CIDP, severe depression, speak consists of constant stuttering.
Age: 49.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Hypoaesthesia, Nerve conduction studies, Nuclear magnetic resonance imaging, Nuclear magnetic resonance imaging brain, Pain in extremity
Clinical narrative: Severe tremors, pain & numbness in feet & legs, and it has moved to upper extremities, trouble concentrating & having memory loss. CIDP, severe depression, speak consists of constant stuttering.
Age: 49.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Tremor
Clinical narrative: Severe tremors, pain & numbness in feet & legs, and it has moved to upper extremities, trouble concentrating & having memory loss. CIDP, severe depression, speak consists of constant stuttering.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Cellulitis, Injection site erythema, Vaccination complication, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Patient presented with red area on Rt thigh near vaccine site. Area raised, very warm to touch. Patient states sore. Vaccines were administered on Tuesday. Evaluated by Dr. Amoxicillin-clavulanate 400/5mg/5ml 8ml 2 times a day 7day.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Pain, Swelling
Clinical narrative: Painful, raised, swollened red spot approximately 2-3" in diameter.
Age: 0.39
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Diarrhoea, Irritability, Vomiting
Clinical narrative: Diarrhea, vomiting, irritable.
Age: 0.39
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Diarrhoea, Irritability, Vomiting
Clinical narrative: Diarrhea, vomiting, irritability.
Age: 36.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site rash, Lip swelling, Swelling face, Urticaria
Clinical narrative: Patient developed hives, swelling to lips/face, rash at site. All symptoms started about 2 hours after receiving TDaP. Received care at local ER, steroids, BENADRYL were given.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Erythema, Oedema peripheral, Tenderness
Clinical narrative: Slight tenderness on deep palpation - 8/29/11. 8/27/11 on Lt arm increased swelling & redness per Dad.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Cough, Lip swelling, Urticaria
Clinical narrative: Hives, coughing, swollen lips.
Sex: F
Vaccine: FLUX, FLUX, FLU3
Symptoms: Anaphylactic reaction, Apnoea, Cardioversion, Death, Hypotension
Clinical narrative: This literature report (initial receipt 10-JUN-2011) concerns a geriatric female patient with a medical history of hypertension and penicillin allergy. On an unknown date, the patient received influenza vaccine. Two minutes after receiving the vaccine, the patient experienced anaphylaxis. The patient experienced apnea, tongue swelling, hypotension and respiratory arrest. The patient was treated with defibrillation and epinephrine x3. The event outcome was fatal.
Sex: F
Vaccine: FLUX, FLUX, FLU3
Symptoms: Respiratory arrest, Swollen tongue
Clinical narrative: This literature report (initial receipt 10-JUN-2011) concerns a geriatric female patient with a medical history of hypertension and penicillin allergy. On an unknown date, the patient received influenza vaccine. Two minutes after receiving the vaccine, the patient experienced anaphylaxis. The patient experienced apnea, tongue swelling, hypotension and respiratory arrest. The patient was treated with defibrillation and epinephrine x3. The event outcome was fatal.
Sex: M
Vaccine: FLU3, FLU3, FLU3
Symptoms: Blood test normal, Computerised tomogram head, Computerised tomogram normal, Grand mal convulsion, Nuclear magnetic resonance imaging brain normal
Clinical narrative: Report received from a nurse on 18-OCT-2010. A male patient aged in his late 60's received a flu shot (brand unknown) on an unknown date in 2009. It is unknown if the patient received the multidose vial or the pre-filled syringe formulation. The patient's concurrent medical conditions included hypertension and hypercholesteraemia. The patient had no drug allergies. Concomitant medications included amlodipine, atorvastatin, olmesartan and terazosin. On an unknown date, 1 month after receiving the flu shot, the patient experienced a grand mal seizure. The event outcome is unknown. Of note, the patient experienced the same reaction to suspect drug AFLURIA, 4 days after receiving the flu shot in 2010. Please see linked case 2010026710. Follow up 1 (29 Oct 2010): Confirmation from Physician, patient date of birth, medical conditions, concomitant medications, vaccination. Follow up 2 (10-JUN-2011): patient initials updated. Case correction (26-Aug-2011): Case reviewed, AE 'grand mal seizure' updated to unlisted based on specificity and severity. Case updated to unlisted.
Sex: M
Vaccine: FLU3, FLU3, FLU3
Symptoms: Vaccine positive rechallenge
Clinical narrative: Report received from a nurse on 18-OCT-2010. A male patient aged in his late 60's received a flu shot (brand unknown) on an unknown date in 2009. It is unknown if the patient received the multidose vial or the pre-filled syringe formulation. The patient's concurrent medical conditions included hypertension and hypercholesteraemia. The patient had no drug allergies. Concomitant medications included amlodipine, atorvastatin, olmesartan and terazosin. On an unknown date, 1 month after receiving the flu shot, the patient experienced a grand mal seizure. The event outcome is unknown. Of note, the patient experienced the same reaction to suspect drug AFLURIA, 4 days after receiving the flu shot in 2010. Please see linked case 2010026710. Follow up 1 (29 Oct 2010): Confirmation from Physician, patient date of birth, medical conditions, concomitant medications, vaccination. Follow up 2 (10-JUN-2011): patient initials updated. Case correction (26-Aug-2011): Case reviewed, AE 'grand mal seizure' updated to unlisted based on specificity and severity. Case updated to unlisted.
Sex: M
Vaccine: FLU3, FLU3, FLU3
Symptoms: Blood test normal, Condition aggravated, Grand mal convulsion, Impaired driving ability, Nuclear magnetic resonance imaging brain normal
Clinical narrative: Report received from a nurse on 18-OCT-2010. A male patient aged in his late 60's received a flu shot (brand unknown) on an unknown date in 2009. It is unknown if the patient received the multidose vial or the pre-filled syringe formulation. The patient's concurrent medical conditions included hypertension and hypercholesteraemia. The patient had no drug allergies. Concomitant medications included amlodipine, atorvastatin, olmesartan and terazosin. On an unknown date, 1 month after receiving the flu shot, the patient experienced a grand mal seizure. The event outcome is unknown. Of note, the patient experienced the same reaction to suspect drug AFLURIA, 4 days after receiving the flu shot in 2010. Please see linked case 2010026710. Follow up 1 (29 Oct 2010): Confirmation from Physician, patient date of birth, medical conditions, concomitant medications, vaccination. Follow up 2 (10-JUN-2011): patient initials updated. Case correction (26-Aug-2011): Case reviewed, AE 'grand mal seizure' updated to unlisted based on specificity and severity. Case updated to unlisted.
Sex: M
Vaccine: FLU3, FLU3, FLU3
Symptoms: Nuclear magnetic resonance imaging normal, Vaccine positive rechallenge
Clinical narrative: Report received from a nurse on 18-OCT-2010. A male patient aged in his late 60's received a flu shot (brand unknown) on an unknown date in 2009. It is unknown if the patient received the multidose vial or the pre-filled syringe formulation. The patient's concurrent medical conditions included hypertension and hypercholesteraemia. The patient had no drug allergies. Concomitant medications included amlodipine, atorvastatin, olmesartan and terazosin. On an unknown date, 1 month after receiving the flu shot, the patient experienced a grand mal seizure. The event outcome is unknown. Of note, the patient experienced the same reaction to suspect drug AFLURIA, 4 days after receiving the flu shot in 2010. Please see linked case 2010026710. Follow up 1 (29 Oct 2010): Confirmation from Physician, patient date of birth, medical conditions, concomitant medications, vaccination. Follow up 2 (10-JUN-2011): patient initials updated. Case correction (26-Aug-2011): Case reviewed, AE 'grand mal seizure' updated to unlisted based on specificity and severity. Case updated to unlisted.
Sex: M
Vaccine: FLU3, FLU3, FLU3
Symptoms: Grand mal convulsion, Vaccine positive rechallenge
Clinical narrative: Report received from a nurse on 18-OCT-2010. A male patient aged in his late 60's received a flu shot (brand unknown) on an unknown date in 2009. It is unknown if the patient received the multidose vial or the pre-filled syringe formulation. The patient's concurrent medical conditions included hypertension and hypercholesteraemia. The patient had no drug allergies. Concomitant medications included amlodipine, atorvastatin, olmesartan and terazosin. On an unknown date, 1 month after receiving the flu shot, the patient experienced a grand mal seizure. The event outcome is unknown. Of note, the patient experienced the same reaction to suspect drug AFLURIA, 4 days after receiving the flu shot in 2010. Please see linked case 2010026710. Follow up 1 (29 Oct 2010): Confirmation from Physician, patient date of birth, medical conditions, concomitant medications, vaccination. Follow up 2 (10-JUN-2011): patient initials updated. Case correction (26-Aug-2011): Case reviewed, AE 'grand mal seizure' updated to unlisted based on specificity and severity. Case updated to unlisted.
Age: 22.0
Sex: F
Vaccine: JEV1, JEV1
Symptoms: Headache, Pruritus, Rash, Urticaria
Clinical narrative: The following case report information was downloaded from VAERS homepage on 16 Aug 2011. A 22 year old female received IXIARO (batch number JEV09M39A) i.m. into the left arm on 18 May 2011. Medical history includes thyroid condition. 24 hours later, patient developed hives (mostly on stomach), rash, itching and headache. After consultation patient took BENADRYL orally, symptoms subsided. 48 hours after vaccination symptoms recurred and subsided after an additional BENADRYL. The outcome of the events was recovered at time of report. Patient was not evaluated in person by a physician.
Age: 1.03
Sex: M
Vaccine: VARCEL
Symptoms: Injection site reaction, Weight bearing difficulty
Clinical narrative: Patient refuses to bear weight on left leg.  Shot was in left thigh.  No apparent tenderness, redness, swelling on affected leg.
Age: 55.0
Sex: F
Vaccine: HEP
Symptoms: Cholelithiasis, Flatulence, Hepatic enzyme increased, Pancreatic duct obstruction, Pancreatitis
Clinical narrative: 1st vomited on 7/31. I vomited again on Aug. 5. I had gas pains spreading up my back. I received a 2nd Hep B vaccine on Aug. 8th
Age: 55.0
Sex: F
Vaccine: HEP
Symptoms: Ultrasound biliary tract, Ultrasound scan abnormal, Vomiting
Clinical narrative: 1st vomited on 7/31. I vomited again on Aug. 5. I had gas pains spreading up my back. I received a 2nd Hep B vaccine on Aug. 8th